- Management of Antiviral Resistance in Chronic Hepatitis B
-
Lim YS
- KMID: 2412184
- Gut Liver.
- 2017 Mar;11(2):189-195.
- doi: 10.5009/gnl15562
The primary goal of therapy for chronic hepatitis B (CHB) is to prevent liver disease progression. Hepatitis B surface antigen (HBsAg) seroclearance or seroconversion is regarded as an optimal endpoint... -
- CITED
-
- Close
- SHARE
-
- Close
- Entecavir to Telbivudine Switch Therapy in Entecavir-Treated Patients with Undetectable Hepatitis B Viral DNA
-
Kim DH, Choi JW, Seo JH, Cho YS, Won SY, Park BK, Jeon HH, Shin SY, Lee CK
- KMID: 2419112
- Yonsei Med J.
- 2017 May;58(3):552-556.
- doi: 10.3349/ymj.2017.58.3.552
PURPOSE: This study examined 2-year outcome of consecutive therapy using entecavir (ETV) followed by telbivudine (LdT) in subjects with undetectable hepatitis B virus (HBV) DNA level and normal alanine aminotransferase... -
- CITED
-
- Close
- SHARE
-
- Close
- Lamivudine Therapy for Korean Children with Chronic Hepatitis B
-
Koh H, Baek SY, Chung KS
- KMID: 1786205
- Yonsei Med J.
- 2007 Dec;48(6):927-933.
- doi: 10.3349/ymj.2007.48.6.927
PURPOSE: Lamivudine is known to be very effective in suppressing hepatitis B virus replication and virus induced necroinflammation. The aim of this study was to evaluate lamivudine therapy efficacy,... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients
-
Kim HJ, Cho JY, Kim YJ, Gwak GY, Paik YH, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH
- KMID: 2129661
- Korean J Intern Med.
- 2015 Jan;30(1):32-41.
- doi: 10.3904/kjim.2015.30.1.32
BACKGROUND/AIMS: The efficacy of tenofovir disoproxil fumarate (TDF) for the treatment of chronic hepatitis B (CHB) patients following prior treatment failure with multiple nucleos(t)ide analogues (NAs) is not well defined,... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term virological outcome in chronic hepatitis B patients with a partial virological response to entecavir
-
Jo YJ, Kim KA, Lee JS, Kim NH, Bae WK, Song TJ, Kim JW
- KMID: 2160681
- Korean J Intern Med.
- 2015 Mar;30(2):170-176.
- doi: 10.3904/kjim.2015.30.2.170
BACKGROUND/AIMS: The clinical outcome of patients with a partial virological response (PVR) to entecavir (ETV), in particular nucloes(t)ide analogue (NA)-experienced patients, has not been thoroughly investigated. The aim of the... -
- CITED
-
- Close
- SHARE
-
- Close
